Vaccine Contract Manufacturing Market Size, Share & Trends Analysis Report By Vaccine Type (Attenuated, Inactivated), By Workflow (Downstream, Upstream), By Application (Human, Veterinary), By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased Database
                        1.4.2. GVR’s Internal Database
                    1.5. Details of primary research
                        1.5.1. Data for primary interviews in North America
                        1.5.2. Data for primary interviews in Europe
                        1.5.3. Data for primary interviews in Asia Pacific
                        1.5.4. Data for primary interviews in Latin America
                        1.5.5. Data for Primary interviews in MEA
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                            1.7.1.1. Approach 1: Commodity flow approach
                        1.7.2. Volume price analysis (Model 2)
                            1.7.2.1. Approach 2: Volume price analysis
                    1.8. Research Scope and Assumptions
                        1.8.1. List of Secondary Sources
                        1.8.2. List of Primary Sources
                        1.8.3. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. Vaccine Contract Manufacturing Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Capacity expansion by contract manufacturers for vaccine manufacturing
                            3.2.1.2. Global increase in vaccination coverage
                            3.2.1.3. Vaccination innovation and robust vaccine pipeline
                            3.2.1.4. Cost and time-saving benefits offered by contract services
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Limited outsourcing by well-established vaccine manufacturers
                    3.3. Technology Landscape
                    3.4. Vaccine Contract Manufacturing Market Analysis Tools
                        3.4.1. Porter’s Five Forces Analysis
                        3.4.2. PESTEL Analysis
                    3.5. COVID-19 Impact Analysis
Chapter 4. Vaccine Contract Manufacturing Market: Type Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Vaccine Contract Manufacturing Market: Type Movement Analysis
                    4.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
                    4.4. Attenuated Vaccine
                        4.4.1. Attenuated Vaccine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.5. Inactivated Vaccine
                        4.5.1. Inactivated Vaccine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.6. Subunit Vaccines
                        4.6.1. Subunit Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.7. Toxoid Vaccines
                        4.7.1. Toxoid Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.8. DNA Vaccines
                        4.8.1. DNA Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Vaccine Contract Manufacturing Market: Workflow Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Vaccine Contract Manufacturing Market: Workflow Movement Analysis
                    5.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
                    5.4. Downstream
                        5.4.1. Downstream Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.2. Fill & Finish Operations
                            5.4.2.1. Fill & Finish Operations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.3. Analytical & QC Studies
                            5.4.3.1. Analytical & QC Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.4. Packaging
                            5.4.4.1. Packaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.5. Upstream
                        5.5.1. Upstream Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.2. Mammalian Expression Systems
                            5.5.2.1. Mammalian Expression Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.3. Bacterial Expression Systems
                            5.5.3.1. Bacterial Expression Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.4. Yeast Expression Systems
                            5.5.4.1. Yeast Expression Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.5. Baculovirus/Insect Expression Systems
                            5.5.5.1. Baculovirus/Insect Expression Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.5.6. Others
                        5.5.7. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Vaccine Contract Manufacturing Market: Type Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Vaccine Contract Manufacturing Market: Type Movement Analysis, USD Million, 2022 & 2030
                    6.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
                    6.4. Viral
                        6.4.1. Viral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.5. Bacterial
                        6.5.1. Bacterial Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.6. Others
                        6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Vaccine Contract Manufacturing Market: Product Type Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. Vaccine Contract Manufacturing Market: Product Type Movement Analysis, USD Million, 2022 & 2030
                    7.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
                    7.4. Single Vaccines
                        7.4.1. Single Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.5. Combination Vaccines
                        7.5.1. Combination Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Vaccine Contract Manufacturing Market: Phase Estimates & Trend Analysis
                    8.1. Segment Dashboard
                    8.2. Vaccine Contract Manufacturing Market: Phase Movement Analysis, USD Million, 2022 & 2030
                    8.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, by Phase, 2018 to 2030 (USD Million)
                    8.4. Preclinical
                        8.4.1. Preclinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.5. Clinical
                        8.5.1. Clinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.6. Commercial
                        8.6.1. Commercial Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Vaccine Contract Manufacturing Market: Application Estimates & Trend Analysis
                    9.1. Segment Dashboard
                    9.2. Vaccine Contract Manufacturing Market: Application Movement Analysis, USD Million, 2022 & 2030
                    9.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
                    9.4. Human Use
                        9.4.1. Human Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    9.5. Veterinary
                        9.5.1. Veterinary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Vaccine Contract Manufacturing Market: Scale of Operation Estimates & Trend Analysis
                    10.1. Segment Dashboard
                    10.2. Vaccine Contract Manufacturing Market: Scale of Operation Movement Analysis, USD Million, 2022 & 2030
                    10.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, by Scale of Operation, 2018 to 2030 (USD Million)
                    10.4. Small Scale
                        10.4.1. Small Scale Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    10.5. Medium Scale
                        10.5.1. Medium Scale Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    10.6. Large Scale
                        10.6.1. Large Scale Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 11. Vaccine Contract Manufacturing Market: Service Type Estimates & Trend Analysis
                    11.1. Segment Dashboard
                    11.2. Vaccine Contract Manufacturing Market: Service Type Movement Analysis, USD Million, 2022 & 2030
                    11.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, by Service Type, 2018 to 2030 (USD Million)
                    11.4. Fill-Finish
                        11.4.1. Fill-Finish Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    11.5. Bulk Products
                        11.5.1. Bulk Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 12. Vaccine Contract Manufacturing Market: End Use Estimates & Trend Analysis
                    12.1. Segment Dashboard
                    12.2. Vaccine Contract Manufacturing Market: End Use Movement Analysis, USD Million, 2022 & 2030
                    12.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
                    12.4. Biopharmaceutical Companies
                        12.4.1. Biopharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    12.5. Research Academies & Government Institutes
                        12.5.1. Research Academies & Government Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 13. Vaccine Contract Manufacturing Market: Regional Estimates & Trend Analysis, by Services, by workflow, by type, by product type, by phase, by application, by scale of operation, by service type, by end use
                    13.1. Vaccine Contract Manufacturing Market: Regional Movement Analysis, 2022 & 2030
                    13.2. North America
                        13.2.1. North America Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.2.2. U.S.
                            13.2.2.1. Key Country Dynamics
                            13.2.2.2. Competitive Scenario
                            13.2.2.3. Regulatory Framework
                            13.2.2.4. U.S. Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.2.3. Canada
                            13.2.3.1. Key Country Dynamics
                            13.2.3.2. Competitive Scenario
                            13.2.3.3. Regulatory Framework
                            13.2.3.4. Canada Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    13.3. Europe
                        13.3.1. Europe Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.3.2. UK
                            13.3.2.1. Key Country Dynamics
                            13.3.2.2. Competitive Scenario
                            13.3.2.3. Regulatory Framework
                            13.3.2.4. UK Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.3.3. Germany
                            13.3.3.1. Key Country Dynamics
                            13.3.3.2. Competitive Scenario
                            13.3.3.3. Regulatory Framework
                            13.3.3.4. Germany Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.3.4. France
                            13.3.4.1. Key Country Dynamics
                            13.3.4.2. Competitive Scenario
                            13.3.4.3. Regulatory Framework
                            13.3.4.4. France Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.3.5. Italy
                            13.3.5.1. Key Country Dynamics
                            13.3.5.2. Competitive Scenario
                            13.3.5.3. Regulatory Framework
                            13.3.5.4. Italy Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.3.6. Spain
                            13.3.6.1. Key Country Dynamics
                            13.3.6.2. Competitive Scenario
                            13.3.6.3. Regulatory Framework
                            13.3.6.4. Spain Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.3.7. Denmark
                            13.3.7.1. Key Country Dynamics
                            13.3.7.2. Competitive Scenario
                            13.3.7.3. Regulatory Framework
                            13.3.7.4. Denmark Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.3.8. Sweden
                            13.3.8.1. Key Country Dynamics
                            13.3.8.2. Competitive Scenario
                            13.3.8.3. Regulatory Framework
                            13.3.8.4. Sweden Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.3.9. Norway
                            13.3.9.1. Key Country Dynamics
                            13.3.9.2. Competitive Scenario
                            13.3.9.3. Regulatory Framework
                            13.3.9.4. Norway Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    13.4. Asia Pacific
                        13.4.1. Asia Pacific Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.4.2. Japan
                            13.4.2.1. Key Country Dynamics
                            13.4.2.2. Competitive Scenario
                            13.4.2.3. Regulatory Framework
                            13.4.2.4. Japan Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.4.3. China
                            13.4.3.1. Key Country Dynamics
                            13.4.3.2. Competitive Scenario
                            13.4.3.3. Regulatory Framework
                            13.4.3.4. China Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.4.4. India
                            13.4.4.1. Key Country Dynamics
                            13.4.4.2. Competitive Scenario
                            13.4.4.3. Regulatory Framework
                            13.4.4.4. India Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.4.5. Australia
                            13.4.5.1. Key Country Dynamics
                            13.4.5.2. Competitive Scenario
                            13.4.5.3. Regulatory Framework
                            13.4.5.4. Australia Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.4.6. Thailand
                            13.4.6.1. Key Country Dynamics
                            13.4.6.2. Competitive Scenario
                            13.4.6.3. Regulatory Framework
                            13.4.6.4. Thailand Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.4.7. South Korea
                            13.4.7.1. Key Country Dynamics
                            13.4.7.2. Competitive Scenario
                            13.4.7.3. Regulatory Framework
                            13.4.7.4. South Korea Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    13.5. Latin America
                        13.5.1. Latin America Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.5.2. Brazil
                            13.5.2.1. Key Country Dynamics
                            13.5.2.2. Competitive Scenario
                            13.5.2.3. Regulatory Framework
                            13.5.2.4. Brazil Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.5.3. Mexico
                            13.5.3.1. Key Country Dynamics
                            13.5.3.2. Competitive Scenario
                            13.5.3.3. Regulatory Framework
                            13.5.3.4. Mexico Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.5.4. Argentina
                            13.5.4.1. Key Country Dynamics
                            13.5.4.2. Competitive Scenario
                            13.5.4.3. Regulatory Framework
                            13.5.4.4. Argentina Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    13.6. Middle East & Africa
                        13.6.1. Middle East & Africa Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.6.2. South Africa
                            13.6.2.1. Key Country Dynamics
                            13.6.2.2. Competitive Scenario
                            13.6.2.3. Regulatory Framework
                            13.6.2.4. South Africa Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.6.3. Saudi Arabia
                            13.6.3.1. Key Country Dynamics
                            13.6.3.2. Competitive Scenario
                            13.6.3.3. Regulatory Framework
                            13.6.3.4. Saudi Arabia Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.6.4. UAE
                            13.6.4.1. Key Country Dynamics
                            13.6.4.2. Competitive Scenario
                            13.6.4.3. Regulatory Framework
                            13.6.4.4. UAE Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        13.6.5. Kuwait
                            13.6.5.1. Key Country Dynamics
                            13.6.5.2. Competitive Scenario
                            13.6.5.3. Regulatory Framework
                            13.6.5.4. Kuwait Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 14. Competitive Landscape
                    14.1. Company Categorization
                    14.2. Company Market Share Analysis, 2023
                    14.3. Strategy Mapping
                    14.4. Company Profiles/Listing
                        14.4.1. Lonza
                            14.4.1.1. Overview
                            14.4.1.2. Financial Performance
                            14.4.1.3. Product Benchmarking
                            14.4.1.4. Strategic Initiatives
                        14.4.2. FUJIFILM Diosynth Biotechnologies
                            14.4.2.1. Overview
                            14.4.2.2. Financial Performance
                            14.4.2.3. Product Benchmarking
                            14.4.2.4. Strategic Initiatives
                        14.4.3. Ajinomoto Co., Inc.
                            14.4.3.1. Overview
                            14.4.3.2. Financial Performance
                            14.4.3.3. Product Benchmarking
                            14.4.3.4. Strategic Initiatives
                        14.4.4. Merck KGaA
                            14.4.4.1. Overview
                            14.4.4.2. Financial Performance
                            14.4.4.3. Product Benchmarking
                            14.4.4.4. Strategic Initiatives
                        14.4.5. IDT Biologika GmbH
                            14.4.5.1. Overview
                            14.4.5.2. Financial Performance
                            14.4.5.3. Product Benchmarking
                            14.4.5.4. Strategic Initiatives
                        14.4.6. Curia Global, Inc.
                            14.4.6.1. Overview
                            14.4.6.2. Financial Performance
                            14.4.6.3. Product Benchmarking
                            14.4.6.4. Strategic Initiatives
                        14.4.7. ICON plc.
                            14.4.7.1. Overview
                            14.4.7.2. Financial Performance
                            14.4.7.3. Product Benchmarking
                            14.4.7.4. Strategic Initiatives
                        14.4.8. Cytovance Biologics (Hepalink)
                            14.4.8.1. Overview
                            14.4.8.2. Financial Performance
                            14.4.8.3. Product Benchmarking
                            14.4.8.4. Strategic Initiatives
                        14.4.9. Syngene International Limited
                            14.4.9.1. Overview
                            14.4.9.2. Financial Performance
                            14.4.9.3. Product Benchmarking
                            14.4.9.4. Strategic Initiatives
                        14.4.10. Catalent, Inc
                            14.4.10.1. Overview
                            14.4.10.2. Financial Performance
                            14.4.10.3. Product Benchmarking
                            14.4.10.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 4 Global Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 5 Global Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 6 Global Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 7 Global Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 8 Global Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 9 Global Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 10 Global Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 11 Global Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 12 Global Vaccines Contract Manufacturing, by Region, 2018 - 2030 (USD Million)
Table 13 North America Vaccines Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 14 North America Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 15 North America Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 16 North America Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 17 North America Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 18 North America Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 19 North America Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 20 North America Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 21 North America Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 22 North America Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 23 U.S. Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 24 U.S. Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 25 U.S. Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 26 U.S. Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 27 U.S. Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 28 U.S. Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 29 U.S. Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 30 U.S. Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 31 U.S. Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 32 Canada Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 33 Canada Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 34 Canada Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 35 Canada Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 36 Canada Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 37 Canada Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 38 Canada Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 39 Canada Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 40 Canada Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 41 Mexico Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 42 Mexico Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 43 Mexico Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 44 Mexico Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 45 Mexico Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 46 Mexico Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 47 Mexico Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 48 Mexico Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 49 Mexico Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 50 Europe Vaccines Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 51 Europe Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 52 Europe Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 53 Europe Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 54 Europe Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 55 Europe Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 56 Europe Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 57 Europe Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 58 Europe Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 59 Europe Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 60 Germany Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 61 Germany Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 62 Germany Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 63 Germany Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 64 Germany Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 65 Germany Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 66 Germany Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 67 Germany Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 68 Germany Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 69 UK Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 70 UK Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 71 UK Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 72 UK Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 73 UK Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 74 UK Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 75 UK Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 76 UK Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 77 UK Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 78 France Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 79 France Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 80 France Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 81 France Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 82 France Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 83 France Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 84 France Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 85 France Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 86 France Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 87 Italy Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 88 Italy Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 89 Italy Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 90 Italy Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 91 Italy Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 92 Italy Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 93 Italy Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 94 Italy Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 95 Italy Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 96 Spain Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 97 Spain Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 98 Spain Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 99 Spain Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 100 Spain Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 101 Spain Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 102 Spain Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 103 Spain Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 104 Spain Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 105 Denmark Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 106 Denmark Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 107 Denmark Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 108 Denmark Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 109 Denmark Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 110 Denmark Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 111 Denmark Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 112 Denmark Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 113 Denmark Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 114 Sweden Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 115 Sweden Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 116 Sweden Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 117 Sweden Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 118 Sweden Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 119 Sweden Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 120 Sweden Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 121 Sweden Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 122 Sweden Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 123 Norway Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 124 Norway Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 125 Norway Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 126 Norway Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 127 Norway Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 128 Norway Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 129 Norway Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 130 Norway Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 131 Norway Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 132 Asia Pacific Vaccines Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 133 Asia Pacific Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 134 Asia Pacific Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 135 Asia Pacific Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 136 Asia Pacific Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 137 Asia Pacific Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 138 Asia Pacific Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 139 Asia Pacific Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 140 Asia Pacific Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 141 Asia Pacific Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 142 China Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 143 China Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 144 China Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 145 China Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 146 China Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 147 China Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 148 China Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 149 China Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 150 China Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 151 Japan Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 152 Japan Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 153 Japan Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 154 Japan Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 155 Japan Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 156 Japan Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 157 Japan Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 158 Japan Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 159 Japan Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 160 India Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 161 India Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 162 India Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 163 India Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 164 India Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 165 India Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 166 India Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 167 India Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 168 India Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 169 South Korea Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 170 South Korea Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 171 South Korea Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 172 South Korea Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 173 South Korea Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 174 South Korea Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 175 South Korea Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 176 South Korea Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 177 South Korea Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 178 Australia Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 179 Australia Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 180 Australia Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 181 Australia Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 182 Australia Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 183 Australia Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 184 Australia Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 185 Australia Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 186 Australia Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 187 Thailand Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 188 Thailand Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 189 Thailand Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 190 Thailand Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 191 Thailand Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 192 Thailand Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 193 Thailand Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 194 Thailand Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 195 Thailand Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 196 Latin America Vaccines Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 197 Latin America Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 198 Latin America Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 199 Latin America Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 200 Latin America Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 201 Latin America Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 202 Latin America Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 203 Latin America Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 204 Latin America Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 205 Latin America Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 206 Brazil Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 207 Brazil Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 208 Brazil Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 209 Brazil Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 210 Brazil Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 211 Brazil Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 212 Brazil Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 213 Brazil Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 214 Brazil Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 215 Argentina Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 216 Argentina Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 217 Argentina Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 218 Argentina Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 219 Argentina Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 220 Argentina Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 221 Argentina Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 222 Argentina Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 223 Argentina Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 224 Middle East & Africa Vaccines Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
Table 225 Middle East & Africa Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 226 Middle East & Africa Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 227 Middle East & Africa Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 228 Middle East & Africa Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 229 Middle East & Africa Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 230 Middle East & Africa Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 231 Middle East & Africa Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 232 Middle East & Africa Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 233 Middle East & Africa Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 234 South Africa Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 235 South Africa Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 236 South Africa Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 237 South Africa Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 238 South Africa Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 239 South Africa Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 240 South Africa Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 241 South Africa Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 242 South Africa Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 243 Saudi Arabia Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 244 Saudi Arabia Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 245 Saudi Arabia Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 246 Saudi Arabia Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 247 Saudi Arabia Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 248 Saudi Arabia Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 249 Saudi Arabia Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 250 Saudi Arabia Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 251 Saudi Arabia Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 252 UAE Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 253 UAE Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 254 UAE Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 255 UAE Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 256 UAE Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 257 UAE Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 258 UAE Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 259 UAE Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 260 UAE Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Table 261 Kuwait Vaccines Contract Manufacturing, by Vaccine Type, 2018 - 2030 (USD Million)
Table 262 Kuwait Vaccines Contract Manufacturing, by Workflow, 2018 - 2030 (USD Million)
Table 263 Kuwait Vaccines Contract Manufacturing, by Type, 2018 - 2030 (USD Million)
Table 264 Kuwait Vaccines Contract Manufacturing, by Product Type, 2018 - 2030 (USD Million)
Table 265 Kuwait Vaccines Contract Manufacturing, by Phase, 2018 - 2030 (USD Million)
Table 266 Kuwait Vaccines Contract Manufacturing, by Application, 2018 - 2030 (USD Million)
Table 267 Kuwait Vaccines Contract Manufacturing, by Scale of Operation, 2018 - 2030 (USD Million)
Table 268 Kuwait Vaccines Contract Manufacturing, by Service Type, 2018 - 2030 (USD Million)
Table 269 Kuwait Vaccines Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Vaccines Contract Manufacturing, Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Regional Marketplace: Key Takeaways
Fig. 12 Global Vaccines Contract Manufacturing, for Attenuated, 2018 - 2030 (USD Million)
Fig. 13 Global Vaccines Contract Manufacturing, for Inactivated, 2018 - 2030 (USD Million)
Fig. 14 Global Vaccines Contract Manufacturing, for Subunit-based, 2018 - 2030 (USD Million)
Fig. 15 Global Vaccines Contract Manufacturing, for Toxoid-based, 2018 - 2030 (USD Million)
Fig. 16 Global Vaccines Contract Manufacturing, for DNA-based, 2018 - 2030 (USD Million)
Fig. 17 Global Vaccines Contract Manufacturing, for Downstream, 2018 - 2030 (USD Million)
Fig. 18 Global Vaccines Contract Manufacturing, for Fill & Finish Operations, 2018 - 2030 (USD Million)
Fig. 19 Global Vaccines Contract Manufacturing, for Analytical & QC studies, 2018 - 2030 (USD Million)
Fig. 20 Global Vaccines Contract Manufacturing, for Packaging, 2018 - 2030 (USD Million)
Fig. 21 Global Vaccines Contract Manufacturing, for Upstream, 2018 - 2030 (USD Million)
Fig. 22 Global Vaccines Contract Manufacturing, for Mammalian Expression Systems, 2018 - 2030 (USD Million)
Fig. 23 Global Vaccines Contract Manufacturing, for Bacterial Expression Systems, 2018 - 2030 (USD Million)
Fig. 24 Global Vaccines Contract Manufacturing, for Yeast Expression Systems, 2018 - 2030 (USD Million)
Fig. 25 Global Vaccines Contract Manufacturing, for Baculovirus/Insect Expression Systems, 2018 - 2030 (USD Million)
Fig. 26 Global Vaccines Contract Manufacturing, for Others, 2018 - 2030 (USD Million)
Fig. 27 Global Vaccines Contract Manufacturing, for Viral, 2018 - 2030 (USD Million)
Fig. 28 Global Vaccines Contract Manufacturing, for Bacterial, 2018 - 2030 (USD Million)
Fig. 29 Global Vaccines Contract Manufacturing, for Others, 2018 - 2030 (USD Million)
Fig. 30 Global Vaccines Contract Manufacturing, for Single Vaccines, 2018 - 2030 (USD Million)
Fig. 31 Global Vaccines Contract Manufacturing, for Combination Vaccines, 2018 - 2030 (USD Million)
Fig. 32 Global Vaccines Contract Manufacturing, for Preclinical, 2018 - 2030 (USD Million)
Fig. 33 Global Vaccines Contract Manufacturing, for Clinical, 2018 - 2030 (USD Million)
Fig. 34 Global Vaccines Contract Manufacturing, for Commercial, 2018 - 2030 (USD Million)
Fig. 35 Global Vaccines Contract Manufacturing, for Human Use, 2018 - 2030 (USD Million)
Fig. 36 Global Vaccines Contract Manufacturing, for Veterinary, 2018 - 2030 (USD Million)
Fig. 37 Global Vaccines Contract Manufacturing, for Small Scale, 2018 - 2030 (USD Million)
Fig. 38 Global Vaccines Contract Manufacturing, for Medium Scale, 2018 - 2030 (USD Million)
Fig. 39 Global Vaccines Contract Manufacturing, for Large Scale, 2018 - 2030 (USD Million)
Fig. 40 Global Vaccines Contract Manufacturing, for Fill-Finish, 2018 - 2030 (USD Million)
Fig. 41 Global Vaccines Contract Manufacturing, for Bulk Products, 2018 - 2030 (USD Million)
Fig. 42 Global Vaccines Contract Manufacturing, for Biopharmaceutical Companies, 2018 - 2030 (USD Million)
Fig. 43 Global Vaccines Contract Manufacturing, for Research Academies & Government Institutes, 2018 - 2030 (USD Million)
Fig. 44 Regional Outlook, 2023 & 2030
Fig. 45 North America Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 46 U.S. Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 47 Canada Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 48 Mexico Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 49 Europe Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 50 Germany Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 51 UK Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 52 France Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 53 Italy Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 54 Spain Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 55 Denmark Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 56 Sweden Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 57 Norway Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 58 Asia Pacific Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 59 Japan Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 60 China Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 61 India Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 62 Australia Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 63 South Korea Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 64 Thailand Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 65 Latin America Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 66 Brazil Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 67 Argentina Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 68 Middle East and Africa Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 69 South Africa Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 70 Saudi Arabia Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 71 UAE Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 72 Kuwait Vaccines Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)